Home > Specialists > Neurosurgery > Dr. Long Wang (王泷)
Specialty & Clinical Focus:
Cerebrovascular neurosurgery specialist at Beijing Anzhen Hospital in Beijing, with a clinical focus on Moyamoya disease, cerebral aneurysms, vascular stenosis and occlusion, cerebral vascular malformations, brain hemorrhage, and brain tumors.
Professional Title & Qualifications:
Associate Chief Physician,
Associate Professor,
Master's Supervisor,
Postdoctoral Fellow (USA and Japan).
Hospital & Department：
Beijing Anzhen Hospital, Department of Neurological Disease Center, Department of Neurosurgery
(address: No. 2 Anzhen Road, Chaoyang District, Beijing, 100029)
Dr. Long Wang (王泷) - Neurosurgery Specialist
Personal Biography
Dr. Long Wang is an Associate Chief Physician and Head of the Clinical Treatment Group at the Neurological Disease Center of Beijing Anzhen Hospital. He also serves as an Associate Professor and Master’s Supervisor at Capital Medical University. His clinical work focuses on complex cerebrovascular diseases and brain tumors, supported by postdoctoral training in the United States and Japan and ongoing academic work in neurosurgery.
Why Choose Dr. Long Wang?
Dr. Long Wang brings focused experience in complex cerebrovascular disease and neuro-oncology at Beijing Anzhen Hospital. His overseas fellowship training at Barrow Neurological Institute in the United States and Sapporo Teishinkai Hospital in Japan provides an international academic background that may be valuable for patients comparing specialist-care pathways across borders.
His stated clinical work includes Moyamoya disease, complex cerebral aneurysms, vascular stenosis and occlusion, brain hemorrhage, cerebral vascular malformations, and deep-seated brain tumors. This makes his profile especially relevant for patients who need careful review of prior imaging, vascular findings, surgical history, and existing medical records before considering care in Beijing.
For international patients, a remote specialist-review or pre-travel records preparation pathway can help organize the case background, clarify the key questions for the specialist, and support a more informed decision about whether an in-person pathway in China is worth exploring.
Pre-Travel Case Review & Specialist Liaison
Complex cerebrovascular or brain-tumor cases often require careful review of existing medical records, imaging, prior treatment history, and a clear question list before international travel is considered. MedBridgeNZ can coordinate a pre-travel case review and specialist-liaison pathway for Dr. Long Wang’s Beijing Anzhen Hospital team where available, including client-authorized records preparation, translation coordination, secure document transfer, and appointment request communication.
For patient-authorized enquiries, the relevant third-party hospital or specialist office may review submitted records for appointment triage or preliminary case-screening where available.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Long Wang
Areas of Expertise
Treatment of dizziness and headaches.
Management of carotid artery plaque, carotid artery stenosis, and carotid artery occlusion.
Care for cerebral infarction, cerebral vascular stenosis, and cerebral vascular occlusion.
Surgical treatment for Moyamoya disease, brain hemorrhage, cerebral aneurysms, and cerebral vascular malformations.
Treatment of vertebral artery stenosis, vertebral artery occlusion, and subclavian artery stenosis.
Comprehensive management of various brain tumors, including meningiomas, pituitary tumors, metastatic tumors, trigeminal schwannomas, acoustic neuromas, gliomas, and craniopharyngiomas.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
2,700 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
Nov 2025 - Present: Head of Clinical Treatment Group / Associate Chief Physician, Neurological Disease Center / Department of Neurosurgery, Beijing Anzhen Hospital.
Nov 2023 - Oct 2025: Associate Chief Physician, Department of Neurosurgery, Beijing Hospital.
Oct 2021 - Nov 2023: Deputy Director of the Department / Associate Chief Physician, Cerebrovascular Disease Ward (Neurosurgery III), Sanbo Brain Hospital Capital Medical University.
Dec 2019 - Oct 2021: Associate Chief Physician, Cerebrovascular Disease Ward (Neurosurgery III), Sanbo Brain Hospital Capital Medical University.
Sep 2019 - Dec 2019: Attending Physician, Cerebrovascular Disease Ward (Neurosurgery III), Sanbo Brain Hospital Capital Medical University.
Education & Training
Ph.D. in Surgery (Neurosurgery), Capital Medical University.
Master's Degree in Surgery (Neurosurgery), Capital Medical University.
Aug 2018 - Aug 2019: Stroke Center, Sapporo Teishinkai Hospital, Japan (Mentor: Rokuya Tanikawa).
Sep 2017 - May 2018: Department of Neurosurgery, Barrow Neurological Institute, USA (Mentor: Michael Lawton).
Awards & Honors
2021: Beijing Medical Science Award (Second Prize) for two projects.
2019: World Federation of Neurosurgical Societies (WFNS) "Global Young Neurosurgeon Award".
2019: World Society for Stereotactic and Functional Neurosurgery Meeting "Travel Scholarship".
2019: World Cerebrovascular Disease Conference "Education Scholarship".
2019: World Neurosurgery Course "Gazi Yasargil Scholarship".
2019: Asian Congress of Neurological Surgeons Cerebrovascular Winter Forum "Top Ten Oral Presentations".
2017: "Wang Zhongcheng Outstanding Graduate Scholarship".
2017: Beijing "Outstanding Graduate Student".
2016-2017: Capital Medical University Graduate Second Prize Scholarship.
2016: "Beijing Medical Science Award (Third Prize)" and "Huaxia Medical Science Award (Third Prize)".
Academic & Professional Memberships
Member of the Education Committee, Asian Congress of Neurological Surgeons (ACNS).
Member of the Sino-Japanese Neurosurgical Alliance.
Youth Committee Member, Cerebrovascular Disease Professional Committee of the Chinese Research Hospital Association.
Reviewer for Neurosurgical Review (Impact Factor: 3.042).
Guest Editor-in-Chief for Frontiers in Neurology (Impact Factor: 4.003).
Research & Publications
Published over 30 SCI papers as the first or corresponding author in global neurosurgical journals, including Neurosurgery, Journal of Neurosurgery, World Neurosurgery, and Neurosurgical Review, with a cumulative impact factor exceeding 70.
Research on "Maxillary Artery Bypass for Complex Middle Cerebral Artery Aneurysms" was featured as the cover article in the February 2019 Neurosurgical FOCUS special issue on Cerebral Revascularization.
Principal Investigator for a sub-project of the National Key R&D Program (funding: 500,000 RMB).
Second Principal Investigator for a Beijing Natural Science Foundation Key Project and a Beijing Municipal Science and Technology Commission Capital Characteristic Key Project.
Editor-in-Chief for Springer English monographs: Microneurosurgical Anatomy and Surgical Techniques and Practical Techniques of Carotid Endarterectomy.
Associate Chief Translator/Translator for multiple Chinese medical translations, including Seven Bypass: The Principles and Techniques of Cerebral Revascularization and Endoscopic Endonasal Skull Base and Brain Surgery.
Contributor to the Chinese monograph Micro-Neurosurgical Anatomy and Surgical Techniques (Second Edition).
Selected Peer-Reviewed Publications
Below is a selection of Dr. Wang's peer-reviewed publications provided for this CMS migration:
Wang L, Lu S, Qian H, Shi X. Internal Maxillary Artery Bypass with Radial Artery Graft Treatment of Giant Intracranial Aneurysms. World Neurosurg. 2017 Sep;105:568-584. doi: 10.1016/j.wneu.2017.06.014. Epub 2017 Jun 10. PMID: 28610970
Wang L, Lu S, Qian H, Shi X. Internal Maxillary Bypass for Complex Pediatric Aneurysms. World Neurosurg. 2017 Jul;103:395-403. doi: 10.1016/j.wneu.2017.04.055. Epub 2017 Apr 19. PMID: 28433837
Wang L, Jing L, Pei A, Zhang D. How i do it: individualized bypass strategy with tentative clamping method. Acta Neurochir (Wien). 2024 Aug 31;166(1):356. doi: 10.1007/s00701-024-06248-y. PMID: 39215801
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
How can I request appointment coordination with Dr. Long Wang from outside China?
International patients can contact MedBridgeNZ to request administrative coordination for a remote specialist-review or pre-travel appointment-triage pathway with Dr. Wang’s department at Beijing Anzhen Hospital, where available. With your authorization, MedBridgeNZ helps organize medical records, imaging files, translation coordination, secure document transfer, and appointment request communication. MedBridgeNZ coordinates these administrative steps; medical opinions and clinical decisions are made only by the relevant hospital or licensed specialist.
Does Dr. Wang’s clinical focus align with my brain or vascular condition?
Dr. Wang’s stated clinical focus includes complex cerebrovascular disease, such as carotid artery stenosis, cerebral aneurysms, Moyamoya disease, cerebral vascular malformations, and vascular stenosis or occlusion, as well as various brain tumors. Where available, the relevant third-party specialist office may review submitted records for appointment triage or preliminary case-screening to determine whether the enquiry appears relevant to Dr. Wang’s stated clinical focus.
What logistical support is available if I travel to Beijing for onsite care?
If an onsite hospital pathway is pursued, MedBridgeNZ can assist with appointment request coordination, medical invitation or visa-document coordination support, accommodation coordination, travel planning, translation coordination, and non-clinical bilingual administrative support for hospital visits where separately arranged. MedBridgeNZ does not guarantee appointment availability, clinical suitability, treatment access, or individual medical outcomes.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. For patients seeking support with Dr. Long Wang at Beijing Anzhen Hospital, we can assist with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis, or treatment, and third-party medical or travel costs remain separate unless expressly stated in writing.